The monoclonal antibody revolution has produced a wave of important new therapeutics, but developing effective antibodies remains elusive for many targets and indications. The discovery and ...
Our team tests, rates, and reviews more than 1,500 products each year to help you make better buying decisions and get more from technology. If you're searching for a professional-grade vector ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) announced today the recent initiation of the Phase 2 clinical trial AFFINITY, designed to evaluate opicinumab as an investigational add-on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback